| The Aberrant Expression of Cytokeratin in Plasma Cell Neoplasm | Hiroaki SUZUKI,Katsushige YAMASHIRO,Mitsutoshi KUROSAWA | 69–73 |
| Impact of HLA-DPB1 Matching in Unrelated Allogeneic Stem Cell Transplantation: Results of Two Centers From Turkey | Bülent KANTARCIOĞLU,HÜSEYİN S BEKÖZ,Ipek Y HINDILERDEN,Demet KIVANC,Yeliz D OGRET,Sevgi K. BEŞIŞIK,Fatma S. OGUZ,Deniz SARGIN | 74–84 |
| Kronik Lenfositik Lösemide Risk Faktörü Olarak Endotelyal Nitrik Oksit Sentaz Gen Varyantlari | MUSTAFA PEHLİVAN,Ayse G TOMATIR,Ayşe F NURSAL,Handan H. SAHIN,SACİDE PEHLİVAN | 85–90 |
| Meme Kanserli Hastalarda Yaşam Tarzı Müdahalelerinin Yaşam Kalitesi Üzerine Etkisi | Haleh GHAVAMI,NERİMAN AKYOLCU | 91–99 |
| Mide Kanserli Hastalarda Semptomatik ve Asemptomatik Venöz Tromboembolizmin Prognostik Etkisi | Yakup BOZKAYA,Nuriye ÖZDEMİR,N Serkan DEMIRCI,Gökmen U ERDEM,OZAN YAZICI,Süheyla ARSLAN,Nurullah ZENGİN | 100–109 |
| Prognostic Role of ERCC1 Protein Expression and its Correlation with 18F-FDG Uptake on PET in Patients with Resected Non-Small Cell Lung Cancer | Tuba ŞAHİNOĞLU,SERKAN UYSAL,Ulaş KUMBASAR,Sevgen C ONDER,Rıza DOĞAN,İlhan PAŞAOĞLU,Metin DEMİRCİN | 110–117 |
| Serum Soluble TWEAK Concentration is Decreased in Patients with Hepatocellular Cancer and Low Blood Levels of sTWEAK are Associated with Poor Survival | Mehmet ASİL,Ramazan DERTLİ | 118–126 |
| Meme Kanserinde Serum Chemerin Düzeyi | SERKAN AKIN,Şafak AKIN,Emre GEDİK,Elif HAZNEDAROGLU,Ayse L DOGAN,Mustafa K ALTUNDAG | 127–132 |
| Two Malignant Mesothelioma Cases with Brain Metastasis | Zeynep ORUC,Muhammet A KAPLAN,Idris ORUC,Zuhat URAKÇI,Halis YERLİKAYA,Mehmet KÜÇÜKÖNER,Abdurrahman IŞIKDOĞAN | 133–136 |